Home/Filings/4/0001209191-16-124962
4//SEC Filing

Epizyme, Inc. 4

Accession 0001209191-16-124962

CIK 0001571498operating

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 1:47 PM ET

Size

7.1 KB

Accession

0001209191-16-124962

Insider Transaction Report

Form 4
Period: 2016-06-01
Copeland Robert A
EVP and CSO10% Owner
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2016-06-01$3.54/sh+31,538$111,64531,538 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2016-06-0131,5384,098 total
    Exercise: $3.54Exp: 2023-01-24Common Stock (31,538 underlying)
Footnotes (2)
  • [F1]The exercise reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  • [F2]This option is fully vested.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001571498

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 1:47 PM ET
Size
7.1 KB